Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean M Wingerchuk

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Annals of Neurology|June 14, 2023
Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal AnalysisMasoud Majed, Cristina Valencia Sanchez, Jeffrey L Bennett, et al.
Frontiers in Neurology|July 17, 2020
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence WorldwideJyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Neurology|August 14, 2021
CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 AntibodiesHannah H Zhao-Fleming, Cristina Valencia Sanchez, Elia Sechi, et al.
Neurology|September 3, 2013
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis opticaYujuan Jiao, James P Fryer, Vanda A Lennon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 23, 2018
Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitisElia Sechi, P Pearse Morris, Andrew McKeon, et al.
Multiple Sclerosis and Related Disorders|February 21, 2014
Treatment of Neuromyelitis Optica: Review and RecommendationsDorlan J Kimbrough, Kazuo Fujihara, Anu Jacob, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disordersVyanka Redenbaugh, Mayra Montalvo, Elia Sechi, et al.
Epilepsia|May 31, 2017
Predictive models in the diagnosis and treatment of autoimmune epilepsyDivyanshu Dubey, Jaysingh Singh, Jeffrey W Britton, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2023
Cerebral enhancement in MOG antibody-associated diseasePaul Elsbernd, Laura Cacciaguerra, Karl N Krecke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2023
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorderOrhan Aktas, Hans-Peter Hartung, Michael A Smith, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Annals of Neurology|June 14, 2023
Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal AnalysisMasoud Majed, Cristina Valencia Sanchez, Jeffrey L Bennett, et al.
Frontiers in Neurology|July 17, 2020
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence WorldwideJyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Neurology|August 14, 2021
CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 AntibodiesHannah H Zhao-Fleming, Cristina Valencia Sanchez, Elia Sechi, et al.
Neurology|September 3, 2013
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis opticaYujuan Jiao, James P Fryer, Vanda A Lennon, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 23, 2018
Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitisElia Sechi, P Pearse Morris, Andrew McKeon, et al.
Multiple Sclerosis and Related Disorders|February 21, 2014
Treatment of Neuromyelitis Optica: Review and RecommendationsDorlan J Kimbrough, Kazuo Fujihara, Anu Jacob, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disordersVyanka Redenbaugh, Mayra Montalvo, Elia Sechi, et al.
Epilepsia|May 31, 2017
Predictive models in the diagnosis and treatment of autoimmune epilepsyDivyanshu Dubey, Jaysingh Singh, Jeffrey W Britton, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2023
Cerebral enhancement in MOG antibody-associated diseasePaul Elsbernd, Laura Cacciaguerra, Karl N Krecke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2023
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorderOrhan Aktas, Hans-Peter Hartung, Michael A Smith, et al.
Pageof 19